Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_assertion type Assertion NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_head.
- NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_assertion description "[The present study investigated CYP2C9 in regard to its allelic variants in 23 tumor samples (10 breast tumors, 1 breast tumor cell line, 5 brain tumors, 7 glioma cell lines) with restriction fragment length polymorphism polymerase chain reaction (RFLP-PCR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_provenance.
- NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_assertion evidence source_evidence_literature NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_provenance.
- NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_assertion SIO_000772 16475710 NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_provenance.
- NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_assertion wasDerivedFrom befree-2016 NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_provenance.
- NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_assertion wasGeneratedBy ECO_0000203 NP535722.RA4d-ca3FLZdrUqbsU-81hYbQZUVfyYRNCjtO9e-yICOk130_provenance.